Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Building core strength through financial strategy

This article was originally published in Scrip

Executive Summary

The CRO industry is full to the brim with private equity investment, with companies such as PRA International, ReSearch Pharmaceutical Services (RPS), INC Research, Medpace, Chiltern International and Theorem Clinical Research (formerly Omnicare Clinical Research) all benefiting from the investment injections of the cash rich. However, one CRO has been busily reversing this strategy, by investing in biopharma companies, for the last decade.

You may also be interested in...



Hoops, hoopla, big ideas and diabetes

Perhaps only a man who inherited an enthusiasm for peptides could, without a trace of irony, cast diabetes drug development as the work of a pastry chef. But for David Solomon, the son of a peptide devotee, mixed metaphors and stretched comparisons are simply the spray thrown up by his unbridled enthusiasm for his chosen trade, that of basketball coach to GLP-1 receptor agonist developer Zealand Pharma.

Scrip Asia 100 league tables 2013

How Dennis Gillings took a gamble and built a $3.7bn business

"How the hell will Glaxo need you? You've only got a few people, they've got about 50,000!"

Topics

Related Companies

UsernamePublicRestriction

Register

ID1132679

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel